Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Clinical trial NCT04732845 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04732845
Sponsor: Benjamin Tomlinson
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia

Start date: 2021-04-26
Primary completion: 2025-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.